Insiders Trades

★ Sign in to follow

AO

Andrew Obenshain

CEO

President of SGD

US·SEC (Form 4)

bluebird bio, Inc.

Insider activity · 24 months0 buys4 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 1 saleJan 25 · 0 buys · 1 saleFeb 25 · 0 buys · 1 saleMar 25 · 0 buys · 1 saleApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

41

Company

1

▲ Purchases (0 ops.)

—

▼ Sales (23 ops.)

€325k

Latest filing published 03 Jun 2025 for bluebird bio, Inc..

Filing timeline

BuySale

Andrew Obenshain

Insider track record

Disclosed buys

0

Disclosed sells

23

Signal history

Andrew Obenshain: trading record in brief

Andrew Obenshain is a declared insider of bluebird bio, Inc. (chief executive), with filings sourced from SEC (Form 4). Between 2 February 2021 and 2 June 2025, the trades on record add up to 41 filings.

No open-market purchase appears, only 23 sales worth €325k. Outside the open market, there are 9 share grants. So far in 2025, the count stands at no purchases and 3 sales.

The newest entry dates from 3 June 2025: a transaction, in bluebird bio, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Andrew Obenshain

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

bluebird bio, Inc. (US)

Declarations41 total

●

Andrew Obenshain

President and CEOExecutives2 Jun 2025bluebird bio, Inc.

0SEC

9,300 sharesCommon StockSEC:0000950170-25-081140:1

◆

Andrew Obenshain

President and CEOExecutives2 Jun 2025bluebird bio, Inc.

0SEC

14,820 sharesCommon StockSEC:0000950170-25-081140:2

●

Andrew Obenshain

President and CEOExecutives2 Jun 2025bluebird bio, Inc.

0SEC

14,820 sharesCommon StockSEC:0000950170-25-081140:3

●

Andrew Obenshain

President and CEOExecutives30 May 2025bluebird bio, Inc.

0SEC

9,027 sharesCommon StockSEC:0000950170-25-081140:0

▼

Andrew Obenshain

President and CEOExecutives3 Mar 2025bluebird bio, Inc.

3,610 USD40SEC

921 shares@ US$3.91941.5% of flowCommon StockSEC:0001562180-25-002088:0

◆

Andrew Obenshain

President and CEOExecutives10 Feb 2025bluebird bio, Inc.

0SEC

763 shares0Common StockSEC:0001562180-25-001152:0

▼

Andrew Obenshain

President and CEOExecutives3 Feb 2025bluebird bio, Inc.

636 USD40SEC

86 shares@ US$7.39250.3% of flowCommon StockSEC:0001562180-25-000950:0

▼

Andrew Obenshain

President and CEOExecutives6 Jan 2025bluebird bio, Inc.

1,294 USD34SEC

140 shares@ US$9.240.5% of flowCommon StockSEC:0001562180-25-000269:0

▼

Andrew Obenshain

President and CEOExecutives10 Dec 2024bluebird bio, Inc.

405 USD34SEC

971 shares@ US$0.41730.2% of flowCommon StockSEC:0001562180-24-008362:0

▼

Andrew Obenshain

President and CEOExecutives30 Sept 2024bluebird bio, Inc.

18,270 USD34SEC

34,780 shares@ US$0.52534.9% of flowCommon StockSEC:0001562180-24-007124:1

◆

Andrew Obenshain

President and CEOExecutives30 Sept 2024bluebird bio, Inc.

0SEC

130,000 shares0Common StockSEC:0001562180-24-007124:0

▼

Andrew Obenshain

President and CEOExecutives4 Mar 2024bluebird bio, Inc.

9,311 USD40SEC

6,095 shares@ US$1.52763.6% of flowCommon StockSEC:0001562180-24-002306:0

▼

Andrew Obenshain

President and CEOExecutives5 Feb 2024bluebird bio, Inc.

1,696 USD37SEC

1,879 shares@ US$0.90250.7% of flowCommon StockSEC:0001562180-24-001095:0

▼

Andrew Obenshain

President and CEOExecutives5 Jan 2024bluebird bio, Inc.

4,520 USD37SEC

3,162 shares@ US$1.42941.7% of flowCommon StockSEC:0001562180-24-000363:0

▼

Andrew Obenshain

President and CEOExecutives3 Nov 2023bluebird bio, Inc.

2,555 USD34SEC

807 shares@ US$3.16591.0% of flowCommon StockSEC:0001562180-23-007552:0

▼

Andrew Obenshain

President and CEOExecutives10 Aug 2023bluebird bio, Inc.

59,956 USD24SEC

16,929 shares@ US$3.541622.9% of flowCommon StockSEC:0001562180-23-006277:0

◆

Andrew Obenshain

President and CEOExecutives1 Mar 2023bluebird bio, Inc.

0SEC

67,600 shares0Common StockSEC:0001562180-23-002404:0

◆

Andrew Obenshain

President and CEOExecutives1 Feb 2023bluebird bio, Inc.

9,060 USD22SEC

1,420 shares@ US$6.383.5% of flowCommon StockSEC:0001562180-23-000902:0

▼

Andrew Obenshain

President and CEOExecutives11 Jan 2023bluebird bio, Inc.

24,802 USD38SEC

3,178 shares@ US$7.80439.7% of flowCommon StockSEC:0001562180-23-000409:0

▼

Andrew Obenshain

President and CEOExecutives4 Nov 2022bluebird bio, Inc.

8,101 USD34SEC

1,263 shares@ US$6.41373.5% of flowCommon StockSEC:0001562180-22-007569:0

▼

Andrew Obenshain

President and CEOExecutives4 Aug 2022bluebird bio, Inc.

95,754 USD41SEC

21,805 shares@ US$4.391439.2% of flowCommon StockSEC:0001562180-22-005942:0

◆

Andrew Obenshain

President and CEOExecutives1 Feb 2022bluebird bio, Inc.

0SEC

18,000 shares0Common StockSEC:0001562180-22-001088:0

▼

Andrew Obenshain

President and CEOExecutives10 Jan 2022bluebird bio, Inc.

20,586 USD41SEC

2,190 shares@ US$9.405.4% of flowCommon StockSEC:0001562180-22-000441:1

▼

Andrew Obenshain

President and CEOExecutives11 Jan 2022bluebird bio, Inc.

45,144 USD41SEC

4,683 shares@ US$9.6412.0% of flowCommon StockSEC:0001562180-22-000441:2

▼

Andrew Obenshain

President and CEOExecutives10 Jan 2022bluebird bio, Inc.

7,876 USD40SEC

852 shares@ US$9.24452.9% of flowCommon StockSEC:0001562180-22-000441:0

25 of 41 declarations